Partner Article
Manchester cosmetic supplier Collagen Solutions acquires NZ firm for £6 million
Manchester-based manufacturer and developer of medical grade collagen, Collagen Solutions plc, has announced the acquisition of a New Zealand-based counterpart for £6 million.
The proposed acquisition of Southern Lights Ventures 2002 Ltd. (trading as Southern Lights Biomaterials) is by way of reverse takeover.
In a statement the firm said that the acquisition was “a logical strategic extension and complementary acquisition that provides additional security of supply of high grade collagen.”
The firm also posted their half year results, reporting revenues of £143k compared to a recorded ‘nil’ in the same period last year. However the firm reported pretax losses of £560k.
This was apparently due to an increase in spending, administrative expenses of £467k, (2013: £62k) reflecting the costs of operating a public company and the related regulatory costs and the extensive depreciation of assets.
Dr Stewart White, chief executive officer of Collagen Solutions, commented: “Trading has been in line with management expectations and we have been committed to our strategic objectives - namely, our investment in Research and Development, Manufacturing and Sales and Marketing.
“The company is securing future revenue streams from existing customers in addition to some new and exciting opportunities resulting from our strategic initiatives.”
This was posted in Bdaily's Members' News section by Clare Burnett .
How businesses can reduce workplace safety risks with custom solutions
Tech firm unveils jobs plan after £530,000 backing
SMEs urged to think big at Newcastle event
B Corp is a commitment, not a one-time win
Government must get in gear on vehicle transition
A legacy in stone and spirit
Shaping the future: Your guide to planning reforms
The future direction of expert witness services
Getting people into gear for a workplace return
What to expect in the Spring Statement
Sunderland leading way in UK office supply market
Key construction developments in 2025